Kumba Iron Ore Ltd (KIO)
Johannesburg Exchange · South Africa · prices in ZAC · close of 23 Oct 2026
Key indicators
| Last close | ZAC 21,920.00 |
|---|---|
| 52-week range | 21,414.00 – 39,531.00 |
| Return, 1 month / 3 months | −3.4% / −13.5% |
| Return, 1 year / 3 years | −32.1% / −54.8% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -44.6% |
| Average daily value traded | 10,462.88M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kumba Iron Ore is a mining company based in South Africa that produces iron ore from its mines in the Northern Cape province. The company supplies iron ore to steelmakers and other industrial customers, with much of its output exported to markets in Asia and Europe. Its operations include the Sishen and Kolomela mines, along with processing and rail logistics that move ore to port for shipment.
Kumba Iron Ore Ltd trades under the code KIO on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kumba Iron Ore Ltd (KIO) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 21,920.00 on 23 October 2026.
Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 201 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.1% and over the last three months it fell 13.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -26.1% | ||
| From 52-week high | -43.6% | ||
| Momentum | 8 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.5% | ||
| 6-month return | -31.2% | ||
| 12-month return, skipping the last month | -29.7% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.6% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 10,462.88M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.7% |
|---|---|
| 1 month | −3.4% |
| 3 months | −13.5% |
| 6 months | −31.2% |
| 1 year | −32.1% |
| 3 years | −54.8% |
| 5 years | −45.9% |
Signals
| 50-day / 200-day average | 23,161.26 / 29,656.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 693.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Aug 2023 | ZAC 2,260.0000 |
| 15 Mar 2023 | ZAC 1,500.0000 |
| 17 Aug 2022 | ZAC 2,710.0000 |
| 16 Mar 2022 | ZAC 3,050.0000 |
| 18 Aug 2021 | ZAC 7,269.9997 |
| 10 Mar 2021 | ZAC 4,129.9999 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.